Physician

Jeffrey Glenn Gross, M.D.

According to 2025 Medicare claims, Jeffrey Gross, M.D. (NPI: 1427059351) practices ophthalmology in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is PALMETTO RETINA CENTER LLC (NPI: 1255322806; TIN: 57-0955585) and primary practice location at 29223-1718. Gross is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Gross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 747 traditional Medicare patients, billed 24,037 HCPCS/CPT codes, and received $2,952,421 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 350 prescription claims across 73 beneficiaries totaling $52,735 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 4 records totaling $345. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $777,935 to $2,952,421. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,107	10,234	$777,935
2016	878	9,071	$1,101,840
2017	950	9,642	$1,529,110
2018	1,070	10,172	$1,637,786
2019	1,267	13,947	$2,276,136
2020	1,109	13,232	$2,400,282
2021	978	13,956	$2,768,609
2022	865	16,558	$3,294,398
2023	780	22,771	$3,015,968
2024	747	24,037	$2,952,421

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	98	437	$54,356
2016	82	349	$42,614
2017	85	364	$50,511
2018	133	561	$80,261
2019	163	762	$130,120
2020	135	709	$124,989
2021	123	541	$96,992
2022	93	442	$79,311
2023	90	395	$65,566
2024	73	350	$52,735

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	296	1,551	$98
92014	Established patient complete exam of visual system	353	453	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	377	1,328	$65
92134	Imaging of retina	451	1,556	$29
92250	Photography of the retina	395	649	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolensa	Bromfenac Sodium	42	1,384	$14,770
Lumigan	Bimatoprost	25	1,185	$9,081
Bromfenac Sodium	Bromfenac Sodium	32	878	$5,132
Simbrinza	Brinzolamide/Brimonidine Tart	15	792	$2,850
Lotemax Sm	Loteprednol Etabonate	11	330	$2,830

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$345	Regeneron Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Glenn Gross, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Glenn Gross, M.D. (NPI 1427059351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Glenn Gross, M.D. have ACO affiliation data?

Jeffrey Glenn Gross, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Jeffrey Glenn Gross, M.D.?

Jeffrey Glenn Gross, M.D. is linked to PALMETTO RETINA CENTER LLC (billing NPI 1255322806) in the available physician profile data.

Does Jeffrey Glenn Gross, M.D. have Open Payments data?

Jeffrey Glenn Gross, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.